A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions
Heart FailureCardiac FailureReduced Ventricular Ejection Fraction
Interventions
DRUG

HNO Donor

Infusion

DRUG

Nitroglycerin (NTG)

Infusion

OTHER

Placebo

Infusion

Trial Locations (18)

22042

Inova Heart and Vascular Institute, Falls Church

27710

Duke Advanced Heart and Lung Failure Clinic, Durham

60611

Northwestern Medicine, Chicago

92780

Orange County Research Center, Tustin

5650871

Local Institution, Suita-shi

46202-1218

Indiana University School of Medicine-Indianapolis, Indianapolis

02115

Brigham and Womens Hospital, Boston

466-8560

Local Institution, Nagoya

211-8533

Local Institution, Kawasaki

9713GZ

Local Institution, Groiningen

EH16 4SA

Local Institution, Edinburgh

G4 0SF

Local Institution, Glasgow

G429LF

Local Institution, Glasgow

G51 4TF

Local Institution, Glasgow

HA1 3UJ

Local Institution, Harrow

SE1 1YR

Local Institution, London

sw17 0re

Local Institution, London

SW3 6NP

Local Institution, London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY